McKesson — Feb 4, 2026 release

We remain focused on advancing a strategy to continue delivering sustainable growth and long-term value creation." "As a result of our third quarter performance and operating momentum, we are raising and narrowing our guidance range for fiscal 2026 Adjusted Earnings per Diluted Share to $38.80 to $39.20. These strong outcomes reflect the power of our platforms and the dedication and commitment of Team McKesson, whose focus enables us to execute consistently and deliver high-quality results." Fiscal 2026 Third Quarter Result Summary Third Quarter Year-to-Date ($ in millions, except per share amounts) FY26 FY25 Change FY26 FY25 Change Revenues $ 106,158  $ 95,294  11  % $ 307,135  $ 268,228  15  % Net income attributable to McKesson Corporation 1,186  879  35  3,080  2,035  51  Adjusted Earnings 2 1,155  1,016  14  3,419  2,960  16  Earnings per diluted common share attributable to McKesson Corporation 9.59  6.95  38  24.73  15.80  57  Adjusted Earnings per Diluted Share 2 9.34  8.03  16  27.46  22.97  20  1 See below under "Fiscal 2026 Outlook" for full explanation 2 Adjusted results in this earnings release are non-GAAP financial measures; refer to the accompanying definitions and reconciliation schedules Third quarter revenues were $106.2 billion, an increase of 11% from a year ago, driven by growth in the North American Pharmaceutical segment due to increased prescription volumes from retail national account customers and growth in the distribution of oncology and multispecialt